List of members:
Mr. Øyvin A. Brøymer, Chairman
Øyvin Brøymer has served as Chair of Medistim since 2000. He works as an investor through his own company Intertrade Shipping AS and holds the position of chair in Vistin Pharma ASA. Previous experience includes executive positions in The Aker Group, Hafslund Nycomed ASA and Leif Höegh & Co ASA, as well as broad board room experience from many other companies. He holds a degree in economics and business from the Norwegian School of Management and an MBA from the University of Wisconsin. He is also Chair of the remuneration committee. Term expires 2023.
Mr. Torben Jörgensen, Deputy Chairman
Torben Jørgensen holds a B.S.c. in Economics and is an independent advisor, consultant and board member. He is currently the chairman of the board of Biotage, Atlas Antibodies AB and Genovis AB. He is also the board member of Micropos Medical AB and Advanced Instruments Inc. He is also a member of the remuneration committee. Term expires 2024.
Mr. Lars Rønn, Board Member
Lars Rønn has been a board member of Medistim since 2010. He works as a consultant for Korn Ferry Associates with focus on recruitment of executives within the med-tech area. He has previous experience as Executive Vice President, Sales & Marketing in Ambu, a Danish med-tech company and as CEO in Origio. He has also experience from several positions in Maersk-Medical AS. Rønn holds a BSc in Business, Language & Culture and has a Graduate Diploma in Int. Trade from Copenhagen Business School. He also has a Management Program from INSEAD. He is an independent board member and is member of the audit committee. Term expires 2024..
Ms. Siri Fürst, Board Member
Siri Fürst was elected as a board member of Medistim in 2013. She has been a partner of Considium Consulting Group AS since 2005. She offers expertise in business development and strategy work, in addition to corporate governance and management. She also serves as board member in Norinnova AS, GC Rieber VivoMega AS, Røros Produkter AS, Unicef Norge and JM Hansen AS. She has broad experience from executive positions within strategy, business development, finance and investor relations from management positions in Hafslund, Hafslund Nycomed and DiaGenic. Fürst holds a degree in economics and finance from the Norwegian School of Economics (NHH). She is also a member of the audit committee. She is independent towards the largest shareholders in the company and is on election for a new term on the ordinary general assembly in 2023.
Ms. Tove Raanes, Board Member
Tove Raanes has been board member in Medistim since 2014. She works as an advisor in the investment companies Dyvi Invest AS and Nore-Invest AS and serves as board member in Bouvet ASA, Multiconsult ASA and Krefting AS. Her experience includes strategy, finance and business development from investment companies and management consulting from McKinsey & Company. Raanes holds a MSc from the Norwegian School of Economics (NHH). She is an independent board member and is Chair of the audit committee. Term expires 2024.
Ms. Anthea Arff-Pettersen, Board Member
Anthea Arff-Pettersen is a Partner and Investment Director at Aeternum Capital. She holds a Master’s in Investment Management from Cass Business School and a BSc in Business Administration from the University of Bath. Her previous experiences are from Schroders and M&G investments in London, private equity firm Credo Partners in Oslo, as well as Höegh Autoliners in New York. Term expires 2024.